Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 12.50
+0.75 (6.38%)
Jun 16, 2026, 11:53 AM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 14.69 million as of June 16, 2026. Its market cap has increased by 95.83% in one year.
Market Cap
14.69M
Enterprise Value
14.83M
Revenue
1.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
12.50
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 14.69M, a decrease of -46.16%. That is a compound annual growth rate of -7.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 14.69M | -7.68% |
| Dec 31, 2025 | 15.91M | 135.22% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sareum Holdings | 31.87M |
| ImmuPharma | 30.01M |
| Arecor Therapeutics | 23.60M |
| SkinBioTherapeutics | 22.03M |
| IXICO | 18.86M |
| Aptamer Group | 18.14M |
| Palatin Technologies | 17.05M |
| Cizzle Biotechnology Holdings | 12.54M |